DekaBank Deutsche Girozentrale »

Sagimet Biosciences Inc-a shares owned by DekaBank Deutsche Girozentrale

Quarter-by-quarter ownership of Sagimet Biosciences Inc-a (SGMT) shares owned by DekaBank Deutsche Girozentrale from 13F filings

Historical chart of DekaBank Deutsche Girozentrale investment in Sagimet Biosciences Inc-a

Tip: Access up to 7 years of quarterly data

All positions including Sagimet Biosciences Inc-a held by DekaBank Deutsche Girozentrale consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sagimet Biosciences Inc-a by DekaBank Deutsche Girozentrale

Quarter filed Position value Share count Share price at filing
2024-03-31 $113k 20k 5.65

More positions owned by DekaBank Deutsche Girozentrale

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Procter & Gamble Company (PG)
Merck & Co (MRK)
Johnson & Johnson (JNJ)
Eli Lilly & Co. (LLY)
JPMorgan Chase & Co. (JPM)
Mastercard Incorporated Cl A (MA)
Accenture Plc Ireland Shs Class A (ACN)
Abbvie (ABBV)

View all positions for DekaBank Deutsche Girozentrale

Top funds holding Sagimet Biosciences Inc-a

Point72 Asset Management
BlackRock
NEA Management Company
Blue Owl Capital Holdings
Hillhouse Capital Advisors
Baker Bros. Advisors
Vanguard Group
Jpmorgan Chase & Co
Alyeska Investment Group
Rock Springs Capital Management
Artal Group
Partner Fund Management
Millennium Management
Ikarian Capital
Geode Capital Management

View all funds holding Sagimet Biosciences Inc-a